Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

AGS-16C3F

Copy Product Info
😃Good
Catalog No. T9901A-963
Alias AGS-16M8F

AGS-16C3F is an antibody-drug conjugate (ADC) targeting ENPP3 (also known as CD203c). This product consists of a humanized IgG1 monoclonal antibody against ENPP3 conjugated to the microtubule inhibitor monomethyl auristatin F (MMAF) via a non-cleavable linker. AGS-16C3F functions by specifically binding to ENPP3 on the surface of tumor cells, undergoing internalization, and releasing MMAF intracellularly to induce cell cycle arrest and apoptosis. It exhibits potent anti-tumor and anti-proliferative activity in ENPP3-expressing metastatic renal cell carcinoma (mRCC) and systemic mastocytosis.

AGS-16C3F

AGS-16C3F

Copy Product Info
😃Good
Catalog No. T9901A-963Alias AGS-16M8F
AGS-16C3F is an antibody-drug conjugate (ADC) targeting ENPP3 (also known as CD203c). This product consists of a humanized IgG1 monoclonal antibody against ENPP3 conjugated to the microtubule inhibitor monomethyl auristatin F (MMAF) via a non-cleavable linker. AGS-16C3F functions by specifically binding to ENPP3 on the surface of tumor cells, undergoing internalization, and releasing MMAF intracellularly to induce cell cycle arrest and apoptosis. It exhibits potent anti-tumor and anti-proliferative activity in ENPP3-expressing metastatic renal cell carcinoma (mRCC) and systemic mastocytosis.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mgInquiryInquiryInquiry
5 mgInquiryInquiryInquiry
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Product Introduction

Bioactivity
Description
AGS-16C3F is an antibody-drug conjugate (ADC) targeting ENPP3 (also known as CD203c). This product consists of a humanized IgG1 monoclonal antibody against ENPP3 conjugated to the microtubule inhibitor monomethyl auristatin F (MMAF) via a non-cleavable linker. AGS-16C3F functions by specifically binding to ENPP3 on the surface of tumor cells, undergoing internalization, and releasing MMAF intracellularly to induce cell cycle arrest and apoptosis. It exhibits potent anti-tumor and anti-proliferative activity in ENPP3-expressing metastatic renal cell carcinoma (mRCC) and systemic mastocytosis.
In vitro
AGS-16C3F inhibits proliferation of CD203c-high ROSA cells (96 h IC50: 1.1-2.73 nM), HMC-1.1 (IC50: 109.9 nM), and HMC-1.2 cells (IC50: 146.5 nM). It induces dose-dependent apoptosis (0.5-100 nM, 96-120 h) by disrupting microtubule dynamics [2].
In vivo
In pharmacological studies using NOD-SCID gamma mouse models xenografted with ROSA cells, systemic administration of AGS-16C3F (1 or 4 mg/kg; i.v.; once every 4 days for 4 doses) significantly reduces tumor burden. The treatment leads to a marked decrease in tumor cells within the peripheral blood, bone marrow, and spleen, while significantly prolonging survival without evidence of overt toxicity in complex physiological environments [2].
SynonymsAGS-16M8F
Reactivity
Human
Application
FACS
Functional assay
Antibody Type
Monoclonal
FormulationSupplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition.
Endotoxin<1.0 EU/mg
Antigen Details
Uniprot ID
TargetENPP3/CD203c
Chemical Properties
Antibody Information
IsotypeIgG1
Storage & Solubility Information
Storagestore at low temperature,keep away from direct sunlight | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.

Calculator

  • Dilution Calculator
  • Reconstitution Calculator
Related Tags: buy AGS-16C3F | purchase AGS-16C3F | AGS-16C3F cost | order AGS-16C3F | AGS-16C3F in vivo | AGS-16C3F in vitro